Strategies in Today’s Market for Pricing and Reimbursement Models

EP: 1.Industry Voices on Current Pricing and Reimbursement Models

EP: 2.Navigating Regulatory Barriers within Market Access

EP: 3.Effective Real-World Evidence for Adding Value to a Clinical Trial

EP: 4.Harmonizing the Payer Perspective with Real-World Evidence

EP: 5.Challenges for Bringing Orphan Drugs to Market

Now Viewing

EP: 6.Strategies in Today’s Market for Pricing and Reimbursement Models

EP: 7.The Ins and Outs of Value-Based Contracts: Timing, Evidence, and Risk Alignment

EP: 8.How New Policies are Impacting Market Sustainability

EP: 9.Rethinking Market Strategy within a Patient-Centric Era

In this episode, the panelists provide a candid look at how payers are increasingly open to innovative reimbursement structures—but only if the groundwork is thoughtfully laid. It’s not enough to pitch a novel payment model; manufacturers must bring solutions tied to the payer’s biggest challenges and be ready to share risk.

Key discussion topics include:

• Designing outcome-based contracts aligned with payer data systems.
• When and how to engage payer medical directors in model design.
• Differences in feasibility across pharmacy and medical benefit products.
• Why a strong value proposition must precede any innovative contract.